References for Vaccine Comparison Information
- A severe allergic reaction (anaphylaxis) occurs when a person needs to be treated with epinephrine or EpiPen© or if they must go to the hospital.
- An immediate allergic reaction occurs within 4 hours of being vaccinated and may include symptoms, such as hives, swelling, and wheezing (respiratory distress).
- Weakened immune systems include people with HIV and those with weakened immune response due to other illnesses or medication.
- An autoimmune disease is a condition in which your immune system mistakenly attacks your body. Examples include Type 1 Diabetes, Rheumatoid Arthritis, Multiple Sclerosis, Lupus, etc.
- EUA stands for Emergency Use Authorization. A EUA allows the FDA to authorize vaccines more quickly during a public health emergency.
Pfizer-BioNTech COVID-19 Vaccine: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine
Fact Sheet for Recipients and Caregivers Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 12 Years of Age and Older: https://swuhealth.org/wp-content/uploads/2021/12/Pfizer-EUA-12andup-12-09-2021.pdf#:~:text=The%20FDA-approved%20COMIRNATY%20%28COVID-19%20Vaccine%2C%20mRNA%29%20and%20the,instructions%20for%20use%2C%20can%20be%20used%20interchangeably.%201
Fact Sheet for Recipients and Caregivers Emergency Use Authorization (EUA) of the Moderna COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 18 Years of Age and Older: https://www.fda.gov/media/144638/download
J&J’s Janssen COVID-19 Vaccine Overview and Safety: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
Fact Sheet for Recipients and Caregivers Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 18 Years of Age and Older: https://www.fda.gov/media/146305/download
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021: https://www.cdc.gov/mmwr/volumes/70/wr/mm7009e4.htm
COVID-19 Vaccines for Moderately or Severely Immunocompromised People: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html
FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations: https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations
COVID-19 Vaccine Booster Shots: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html
Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17
Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine Boosters: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters
COVID-19 Vaccine for Children and Teens: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/children-teens.html?s_cid=11370:cdc%20covid%20vaccine%20children:sem.ga:p:RG:GM:gen:PTN:FY21
Pfizer EUA for Individuals 5-11 years old: https://www.fda.gov/media/153717/download
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age: https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age
CDC Recommends Pediatric COVID-19 Vaccine for Children 5 to 11 Years: https://www.cdc.gov/media/releases/2021/s1102-PediatricCOVID-19Vaccine.html
Pfizer EUA for Individuals 12 years of age and older: https://www.fda.gov/media/153716/download
Frequently Asked Questions about Covid-19 Vaccination: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html
Understanding How Covid-19 Vaccines Work: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html
Possible Side Effects After Getting a COVID-19 Vaccine: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html
Covid-19 Vaccines for People with Underlying Medical Conditions: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/underlying-conditions.html
Interim Clinical Considerations for Use of Covid-19 Vaccines Currently Authorized in the United States: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.html#Interchangeability
CDC Real-World Study Confirms Protective Benefits of mRNA COVID-19 Vaccines: https://www.cdc.gov/media/releases/2021/p0329-covid-19-vaccines.html
Interim Estimates of Vaccine Effectiveness of Bnt162b2 and Mrna-1273 Covid-19 Vaccines in Preventing Sars-Cov-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021a: https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e3.htm?s_cid=mm7013e3_w